(Q42982079)

12 November 2017

title

Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion (English)

1 reference

12 November 2017

1 reference

4

1 reference

12 November 2017

author name string

Antigoni S Katsoulidou

1

1 reference

12 November 2017

Zissis M Moschidis

2

1 reference

12 November 2017

Renia E Gialeraki

3

1 reference

12 November 2017

Vana A Sypsa

5

1 reference

12 November 2017

Marios C Lazanas

6

1 reference

12 November 2017

Nicholaos C Tassopoulos

7

1 reference

12 November 2017

Mina A Psichogiou

8

1 reference

12 November 2017

John N Boletis

9

1 reference

12 November 2017

Anastasia S Karafoulidou

10

1 reference

12 November 2017

Angelos E Hatzakis

11

1 reference

12 November 2017

language of work or name

1 reference

1 January 2004

1 reference

12 November 2017

1 reference

12 November 2017

volume

44

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

59-66

1 reference

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

A SHOT in the arm for safer blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Transmission of HIV-1 from seronegative but PCR-positive blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Duration of human immunodeficiency virus infection before detection of antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Sensitivity of serological assays to identify blood donors with hepatitis C viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Genomic screening for blood-borne viruses in transfusion settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Sensitivity of HCV RNA and HIV RNA blood screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Variability of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Correlates of hepatitis C virus infections among injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Sensitivity of the Procleix HIV-1/HCV assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA in a high-risk population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2003.00591.X

10.1111/J.0041-1132.2003.00591.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference